Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
41.55    -1.75 (-4.04%)
Bid:
41.30
Ask:
42.00
Spread: 0.70 (1.695%)
Market Cap: £276.67m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Bonus Issue and Capital Reduction Update

12 Sep 2022 07:00

RNS Number : 0190Z
S4 Capital PLC
12 September 2022
 

12 September 2022

S4 Capital plc

("S4Capital" or "the Company")

 

Bonus Issue and Capital Reduction Update

Further to the publication on 14 May 2022 of the Notice of Annual General Meeting (the "Notice"), and the passing of all the required Resolutions at the Annual General Meeting of the Company on 16 June 2022, the Company announces that the final hearing in the Court process to convert its £205,717,000 merger reserve into a distributable reserve is expected to be held on 13 September 2022 (the "Court Hearing").

As described in the Notice, a bonus issue (the "Bonus Issue") of C ordinary shares, each having a nominal value to be determined as at the date of the Bonus Issue (each a "Capital Reduction Share"), shall occur on the evening of 12 September 2022 (being the day before the Court Hearing). Accordingly, the record time for the bonus issue shall be 6.00 p.m. on 12 September 2022 (the "Record Time"). The nominal value of each Capital Reduction Share shall be determined as described in the Notice. The Board does not intend to declare an interim dividend at this time, although it continues to review the advisability of declaring a modest dividend in future.

One Capital Reduction Share shall be issued for each ordinary share of 25p in issue as at the Record Time. In addition, and as described in the Notice, the Capital Reduction Shares will not be admitted to the standard listing segment of the Official List or to trading on any regulated market. No share certificates will be issued in respect of the Capital Reduction Shares. The Capital Reduction Shares will have extremely limited rights. In particular, the Capital Reduction Shares will carry no rights to vote, no rights to participate in the profits of the Company and no rights to participate in the Company's assets save on a winding-up. The Capital Reduction Shares will be transferable, but it is not expected that any market in them will develop and it is anticipated that the Court will confirm their cancellation at the Court Hearing on the day immediately after the date on which they have been issued.

The Company will announce the outcome of the Court Hearing on 13 September 2022.

Capitalised terms used in this announcement which are not otherwise defined have the same meaning as in the Notice, which is available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website at https://www.s4capital.com/investors.

Enquiries:

S4 Capital plc Tel: +44 (0)20 3793 0003/+44 (0)20 3793 0007

Sir Martin Sorrell (Executive Chairman)

Powerscourt Tel: +44 (0)778 670 2526

(PR Adviser to S4 Capital plc)

 

Robin O'Kelly 

Jane Glover

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFEDARILLIF
Date   Source Headline
4th Jun 20264:30 pmRNSResults of 2026 Annual General Meeting
4th Jun 20267:00 amRNSAGM Statement
13th May 20266:00 pmRNSNotice of AGM
7th May 20267:00 amRNSFirst Quarter Trading Update
30th Apr 20265:00 pmRNSHolding(s) in Company
24th Apr 20265:45 pmRNSAnnual Report and Accounts
15th Apr 20267:00 amRNSNotice of Q1 Trading Update
26th Mar 202612:58 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSAudited 2025 Results
26th Feb 20267:00 amRNSNotice of Results
26th Jan 20267:00 amRNSFourth Quarter Trading Update
1st Dec 20257:00 amRNSTotal Voting Rights
24th Nov 20257:00 amRNSTrading Update
14th Nov 202512:15 pmRNSBoard Changes
6th Nov 20257:01 amRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Trading Update
5th Nov 20257:00 amRNSIssue of Shares
17th Oct 20259:00 amRNSNotice of Q3 Trading Update
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSIssue of Shares
15th Sep 20257:00 amRNSInterim Results for 2025
1st Sep 202511:04 amRNSTotal Voting Rights and Capital
22nd Aug 20257:00 amRNSNotice of Results
15th Aug 20257:00 amRNSIssue of Shares
11th Aug 20257:00 amRNSResponse to Press Speculation
1st Aug 20259:15 amRNSTotal Voting Rights
25th Jul 20257:00 amRNSIssue of Shares
17th Jul 20253:02 pmRNSHolding(s) in Company
3rd Jul 20254:30 pmRNSBoard Change
4th Jun 20253:03 pmRNSResult of AGM
4th Jun 20257:00 amRNSS4 Capital AGM statement
16th May 20253:01 pmRNSDirector/PDMR Shareholding
9th May 20252:30 pmRNSNotice of AGM
8th May 20257:00 amRNSS4 Capital Q1 2025 Trading Update
1st May 20257:00 amRNSBoard Appointments
25th Apr 202511:39 amRNSNotice of Q1 Trading Update
3rd Apr 20259:11 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSAudited 2024 Results
17th Mar 20257:00 amRNSNotice of Results
28th Jan 20257:00 amRNSFourth Quarter Trading Update
9th Jan 20257:00 amRNSManagement Change
2nd Dec 20243:55 pmRNSTotal Voting Rights
15th Nov 20243:30 pmRNSDirector/PDMR Shareholding
15th Nov 20247:00 amRNSIssue of Shares
7th Nov 20247:00 amRNSThird Quarter Trading Update
4th Nov 20247:00 amRNSNotice of Q3 Trading Update
1st Nov 20249:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSIssue of Shares
7th Oct 20247:00 amRNSIssue of Shares
19th Sep 20247:00 amRNSInterim Results for 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.